Silver Book Fact

Economics of DR Treatment

Fact image

Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.

Cost-Effectiveness of Treatment of Diabetic Macular Edema. Ann Intern Med. 2014; 160(1): 160-3. http://annals.org/article.aspx?articleid=1811027

Reference

Title
Cost-Effectiveness of Treatment of Diabetic Macular Edema
Publication
Ann Intern Med
Publication Date
2014
Volume & Issue
Volume 160, Issue 1
Pages
160-3
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • To date, multiple genomewide comparisons of thousands of subjects with type 2 diabetes and controls without the disease have identified approximately twenty-five DNA variants that are significantly associated with type…  
  • An evaluation of the Diabetes Prevention Program lifestyle intervention found that providing this intervention at age 50 could prevent 37% of new cases of diabetes before age 65. If Medicare…  
  • Laser treatments save up to $1.6 billion per year through prevention and treatment of blindness in diabetics.  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • DR Treatment Savings in the US
    Every year, the U.S. saves an estimated $1.6 billion by treating DR.